(RX) Biosyent - Performance 29.5% in 12m
Compare RX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
78.21%
#5 in Group
Rel. Strength
82.77%
#1376 in Universe
Total Return 12m
29.48%
#30 in Group
Total Return 5y
165.69%
#11 in Group
P/E 16.1
24th Percentile in Group
P/E Forward 12.4
42th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield 4.31%
66th Percentile in Group
12m Total Return: RX (29.5%) vs XLV (0.8%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-35.9% | 213% | 500% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
| LLY NYSE Eli Lilly |
7.18% | 20.9% | 513% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
| NVS NYSE Novartis |
1.77% | 21.1% | 76.1% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
| SFZN SW Siegfried Holding |
8.63% | 11.5% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
| NOVN SW Novartis |
-3.71% | 9.8% | 50.6% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
| SOBI ST Swedish Orphan Biovitrum |
1.67% | 3.11% | 56.4% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
| SAN PA Sanofi |
-7.55% | 6.86% | 24.4% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
| SNY NASDAQ Sanofi |
-3.14% | 14.1% | 34% | 18.5 | 11.2 | 0.9 | -52.5% | -47% |
Performance Comparison: RX vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for RX
| Total Return (including Dividends) | RX | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | -1.52% | -4.61% | -0.91% |
| 3 Months | 0.27% | -4.01% | -7.61% |
| 12 Months | 29.48% | 0.78% | 10.06% |
| 5 Years | 165.69% | 54.00% | 110.82% |
| Trend Score (consistency of price movement) | RX | XLV | S&P 500 |
| 1 Month | -4.70% | -23.1% | 1.2% |
| 3 Months | -44.4% | -69% | -89.2% |
| 12 Months | 68.5% | -15.8% | 56.2% |
| 5 Years | 78.1% | 89.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #94 | 3.23% | -0.62% |
| 3 Month | #57 | 4.45% | 8.53% |
| 12 Month | #29 | 28.5% | 17.6% |
| 5 Years | #12 | 72.5% | 26.0% |
FAQs
Does RX Biosyent outperforms the market?
Yes,
over the last 12 months RX made 29.48%, while its related Sector, the Health Care Sector SPDR (XLV) made 0.78%.
Over the last 3 months RX made 0.27%, while XLV made -4.01%.
Over the last 3 months RX made 0.27%, while XLV made -4.01%.
Performance Comparison RX vs Indeces and Sectors
RX vs. Indices RX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 1.58% | -0.61% | 0.90% | 19.4% |
| US NASDAQ 100 | QQQ | -0.28% | -2.93% | 1.42% | 18.9% |
| US Dow Jones Industrial 30 | DIA | 3.31% | 1.93% | 0.13% | 22.2% |
| German DAX 40 | DAX | 1.38% | -2.63% | -18.2% | 6.35% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6.52% | 1.08% | 1.97% | 24.5% |
| Hongkong Hang Seng | HSI | 4.93% | 0.48% | -0.13% | 19.3% |
| India NIFTY 50 | INDA | 6.64% | -5.52% | -0.83% | 26.8% |
| Brasil Bovespa | EWZ | 0.91% | -7.36% | -4.68% | 36.4% |
RX vs. Sectors RX is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 1.26% | -0.44% | -7.17% | 7.62% |
| Consumer Discretionary | XLY | -0.22% | -2.34% | -3.09% | 17.9% |
| Consumer Staples | XLP | 7.93% | -0.99% | -5.55% | 19.6% |
| Energy | XLE | 5.06% | 9.95% | 1.08% | 40.8% |
| Financial | XLF | 3.51% | 0.77% | -7.76% | 8.21% |
| Health Care | XLV | 3.59% | 3.09% | 2.15% | 28.7% |
| Industrial | XLI | 2.18% | -0.92% | -0.05% | 22.4% |
| Materials | XLB | 4.15% | 1.41% | 7.24% | 35.2% |
| Real Estate | XLRE | 5.0% | 0.25% | 1.34% | 14.1% |
| Technology | XLK | -1.94% | -2.79% | 6.87% | 24.6% |
| Utilities | XLU | 5.04% | -2.09% | -4.78% | 7.67% |
| Aerospace & Defense | XAR | -0.77% | -8.46% | -11.8% | 3.46% |
| Biotech | XBI | 1.25% | -2.48% | 13.7% | 33.6% |
| Homebuilder | XHB | 4.86% | 1.58% | 14.9% | 38.9% |
| Retail | XRT | 4.02% | -1.39% | 4.76% | 33.7% |